Test RTE

  • STATUS
    Recruiting
Send
Updated on 19 February 2024
See if I qualify

Summary

Study Overview Study Details Eligibility Trial Primary Objective:
To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
Secondary Objectives:
To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
To continue to assess the safety and tolerability throughout the study
Primary Objective:
To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
Secondary Objectives:
  1. To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
  2. To continue to assess the safety and tolerability throughout the study
Primary Objective:
To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
Secondary Objectives:
  • To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
  • To continue to assess the safety and tolerability throughout the study
Primary Objective:
To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
Secondary Objectives:
To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
To continue to assess the safety and tolerability throughout the study

Description

Study Overview Study Details Eligibility Trial Primary Objective:
To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
Secondary Objectives:
⦁ To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
⦁ To continue to assess the safety and tolerability throughout the study
⦁ To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
⦁ To continue to assess the safety and tolerability throughout the study
Primary Objective:
1. To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
2. To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
3. To continue to assess the safety and tolerability throughout the study
Primary Objective:
To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
Secondary Objectives:
To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
To continue to assess the safety and tolerability throughout the study

Details
Condition Asthma, Asthma, Asthma (Pediatric), Allergies & Asthma, Asthma (Pediatric), Allergies & Asthma
Age 18years - 86years
Clinical Study IdentifierTX12534
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Asthma??
Age : 16 to 45?
Male

Exclusion Criteria

Female
Acne
Age > than 60
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.